A prospective, randomized, open-label study to compare the efficacy and safety of Sterizone® post-operative silver based wound dressing versus standard gauze dressing in women having elective and emergent caesarean section
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- •To compare Sterizone® and standard gauze post-operative surgical dressing for wound composite outcome of one or more of the following: superficial surgical site infection, hematoma, seroma or wound dehiscence within 30 days from the day of surgery.
研究概览
简要总结
Cesarean delivery (also called a cesarean section or C-section) is the surgical delivery of a baby by an incision through the mother’s abdomen (belly) and uterus (womb). This procedure is done when the surgeon determined it to be safer method than vaginal delivery for the mother, baby, or both.
In India, the rates of caesarean deliveries have more than doubled from 8% of deliveries in 2005 to 17% of deliveries in 2016. Surgical site infection (SSI) is one of the most common complications following cesarean section, and has an incidence of 3%–15% (Zuarez-Easton et al., 2017). It places physical and emotional burdens on the mother herself and a significant financial burden on the health care system. Affected women are more likely to have prolonged hospitalization, hospital readmission, reoperation, and additional antibiotic therapy. It is estimated that each SSI adds $3,400-$3,700 to the healthcare costs. Moreover, SSI is associated with a maternal mortality rate of up to 3% (Zuarez-Easton et al., 2017). Given the burden in morbidity and cost, there is a heightened focus on reduction of SSI in association with caesarean delivery.
Because of its unique antimicrobial properties, silver has been used for centuries to reduce infection. Krieger et al, 2011 described silver as a metal that is relatively inert and poorly absorbed by cells. When it is exposed to a wound, it ionizes and becomes highly reactive to proteins and cell membranes. It has been shown to interact with structural proteins and DNA, inhibiting bacterial replications and causing fatal structural changes within bacterial cell walls. Prospective and retrospective studies in other specialties such as colorectal surgery and orthopedic surgery demonstrating a decreased rate of SSI with use of silver dressings have resulted in an interest in its use for cesarean wounds (Abboud et al., 2014).
Sterizone®, a product from Dynamic Techno Medicals Private Limited, is a semi permeable waterproof silver based wound dressing for post-operative applications. Sterizone® post-operative dressing has a silver fabric layer edge laminated between two non-adherent polyethylene (PE) nets (one layer of PE net is the wound contact layer and the other one is laminated to an absorbent pad. The outermost layer is a polyurethane (PU) film which is transparent and waterproof in its nature which prevents the bacterial ingress. The PU film is bonded to the absorbent pad using acrylic adhesive.The metallic silver upon interaction with moisture, generate silver ions and act as an antimicrobial barrier for bacterial penetration of the dressing which may help reduce infection. The ions kill the bacteria bound to the wound and within the dressing. Sterizone® has been subjected to in vitro biocompatibility tests, i.e cytotoxicity, sensitization and irritation to prove its biocompatible nature.
The present study will compare Sterizone® post-operative silver based wound dressing with standard gauze dressing in subjects undergoing cesarean delivery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Permuted block randomization, variable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)(—)
- 性别
- Female
入选标准
- ••Primiparous or multiparous woman aged 18-40 years •Woman having gestation between 24(0/7) and 40(6/7) weeks •Woman with single or multiple gestations •Woman with elective or emergent cesarean deliveries •Woman with primary or repeat cesarean sections •Woman with Pfannenstiel or low transverse skin incisions •Woman with good systemic/mental health as per opinion of the PI •Woman with CDC surgical wound classification class I •Woman providing written informed consent.
排除标准
- ••Woman with BMI > 30 Kg/m2 •Woman with hemoglobin levels < 7g/dL •Woman that did not receive routine prophylactic dose of antibiotics in the operating room.
- ••Woman with skin incisions other than Pfannenstiel or low transverse incisions •Woman requiring more than one incision •Woman having urogenital tract infection within 2 weeks before cesarean delivery •Woman with known or discovered allergy to suture material or silver •Woman with active neoplastic lesion treated with radiation or chemotherapy •Woman requiring MRI (Magnetic Resonance Imaging) examination during the course of the study •Woman with active skin infection, and coagulopathy •Woman prone to develop keloids or have developed keloid with any past surgery •Woman taking systemic immunosuppressant (excluding steroids for lung maturity), or known case of HIV •Woman with high likelihood of additional surgical procedure beyond cesarean (e.g., scheduled hysterectomy, bowel, or adnexal surgery) •Woman already participating in another surgical study •Woman who received an experimental drug or used an experimental medical device within 3 months of becoming pregnant •Woman unlikely to comply with surgical procedure or complete the scheduled follow up visit, in the opinion of PI •Employees of the PI or study center with direct involvement in the proposed study or other studies under the direction of that PI or study center •Any confirmed or suspected SARS-CoV-2virus/variant or COVID-19 disease •Other indication-based exclusion, in opinion of PI.
结局指标
主要结局
•To compare Sterizone® and standard gauze post-operative surgical dressing for wound composite outcome of one or more of the following: superficial surgical site infection, hematoma, seroma or wound dehiscence within 30 days from the day of surgery.
时间窗: Day0 Day3to8 Day9to15 Day30/Early Termination visits
次要结局
- •To evaluate peri-incisional skin condition or inflammation(•To evaluate time to appearance of surgical site infection (and subtypes), hematoma, seroma or wound dehiscence)
